Ingredient innovation moves faster than regulation. Botanicals, novel actives, new extraction methods and imported ingredients often have no entry in the FSSAI schedules — which means a brand that wants to use them must first establish a regulatory pathway, supported by a safety dossier that stands up to scientific scrutiny.
This is among the most technical work in Indian food regulation, and it is a core specialisation of our practice: mapping the pathway, assembling the evidence, and carrying the application through review.
Who is this service for?
- Ingredient suppliers introducing new actives to the Indian market
- Brands formulating with botanicals or nutrients outside current schedules
- Importers whose ingredients are approved abroad but not in India
- R&D teams validating ingredient viability before formulation investment
What is included?
- Regulatory status check of the ingredient across FSSAI schedules
- Pathway determination and precedent analysis
- Scientific literature review and safety-evidence compilation
- Full dossier: identity, specifications, manufacturing, exposure assessment, safety data
- Application filing and technical query handling
How does the process work?
- 1Ingredient screening and pathway report
- 2Evidence gap analysis
- 3Dossier compilation with specification development
- 4Submission and review support through decision
Which documents will you need?
- Ingredient identity and full specification
- Manufacturing process description
- Existing safety studies and international approvals if any
- Intended use levels and target product categories
How long does it take?
Pathway screening typically takes 1–2 weeks. Dossier preparation depends on how much safety evidence already exists; regulator review of novel-ingredient applications is a multi-month process by nature.
Common mistakes we correct
- Treating a US GRAS or EU Novel Food status as automatically valid in India
- Dossiers missing exposure assessment for the Indian dietary context
- Specifications that do not match the actual commercial material
Frequently Asked Questions
My ingredient is approved in the US/EU — can I use it in India?
Not automatically. International approvals are persuasive evidence inside an Indian dossier but India requires its own assessment for ingredients outside the FSSAI schedules. The good news: strong foreign dossiers substantially accelerate the Indian application.
What makes a safety dossier credible?
Primary evidence: identity and purity specifications, toxicological data or authoritative reviews, documented history of safe use, and an exposure assessment tied to proposed use levels. Marketing claims and secondary citations do not carry an application.
Can we sell while the application is pending?
No — an unscheduled ingredient without approval cannot lawfully be sold in food. Sequencing launch plans around the regulatory timeline is part of our engagement.
Regulations that apply
- FSS (Approval for Non-Specified Food and Food Ingredients) Regulations, 2017
- FSS (Health Supplements, Nutraceuticals…) Regulations — permitted-ingredient schedules